S. Hasuike

发表

Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator.

A. Iwama, K. Nagata, K. Aoyama, 2015, Blood.

MYELOID NEOPLASIA Loss of TET 2 has dual roles in murine myeloproliferative neoplasms : disease sustainer and disease accelerator

A. Iwama, K. Nagata, K. Aoyama, 2014 .

TET2 is essential for survival and hematopoietic stem cell homeostasis

A. Iwama, K. Nagata, K. Shimoda, 2012, Leukemia.

Osteoactivin expressed during cirrhosis development in rats fed a choline-deficient, L-amino acid-defined diet, accelerates motility of hepatoma cells.

K. Nagata, A. Ido, A. Moriuchi, 2003, Journal of hepatology.

A CRE and the region occupied by a protein induced by growth factors contribute to up-regulation of cyclin D1 expression in hepatocytes.

S. Hirono, K. Hayashi, K. Nagata, 2003, Biochemical and biophysical research communications.

The peroxisome proliferator-activated receptor-gamma agonist, pioglitazone, inhibits fat accumulation and fibrosis in the livers of rats fed a choline-deficient, l-amino acid-defined diet.

K. Hayashi, K. Nagata, A. Ido, 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosis

M. Ikawa, K. Nagata, K. Shimoda, 2019, Blood Cancer Journal.

Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib

K. Nagata, A. Sawaguchi, K. Shimoda, 2016, Leukemia.

Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F

K. Takenaka, K. Karube, K. Ohshima, 2008, Leukemia.

Spontaneous elimination of hepatitis C virus RNA in individuals with persistent infection in a hyperendemic area of Japan.

K. Hayashi, M. Kohara, K. Nagata, 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

Surrounding Gastric Mucosa Findings Facilitate Diagnosis of Gastric Neoplasm as Gastric Adenoma or Early Gastric Cancer

K. Nagata, K. Shimoda, T. Miike, 2015, Gastroenterology research and practice.

Clinical Study Surrounding Gastric Mucosa Findings Facilitate Diagnosis of Gastric Neoplasm as Gastric Adenoma or Early Gastric Cancer

K. Nagata, K. Shimoda, T. Miike, 2016 .

Gene expression profiling of loss of TET2 and/or JAK2V617F mutant hematopoietic stem cells from mouse models of myeloproliferative neoplasms

A. Iwama, K. Nagata, K. Aoyama, 2015, Genomics data.

Liver abscess in advanced hepatocellular carcinoma after atezolizumab plus bevacizumab treatment: A case report

K. Uchida, H. Kawakami, Hisayoshi Iwakiri, 2022, Medicine.

Bridging use of plasma exchange and continuous hemodiafiltration before living donor liver transplantation in fulminant Wilson's disease.

K. Hayashi, A. Ido, H. Tsubouchi, 2003, Internal medicine.

Efficacy and safety of glecaprevir and pibrentasvir in Japanese patients with hepatitis C virus infection aged 75 years or older

S. Hirono, K. Nagata, T. Miike, 2022, BMC Gastroenterology.

CD3 and EBER double positive cells in bone marrow are a diagnostic aid for EBV-positive T-cell lymphoproliferative disorders of childhood

K. Nagata, K. Shimoda, Shojiro Yamamoto, 2012, International Cancer Conference Journal.

Hepatocyte growth factor accelerates the proliferation of hepatic oval cells and possibly promotes the differentiation in a 2‐acetylaminofluorene/partial hepatectomy model in rats

K. Hayashi, K. Nagata, A. Ido, 2005, Journal of gastroenterology and hepatology.

Enhanced expression of growth factors and imbalance between hepatocyte proliferation and apoptosis in the livers of rats fed a choline-deficient, L-amino acid-defined diet

Katsuhiro Hayashi, A. Ido, A. Moriuchi, 2004 .

Improvement of rheumatoid arthritis and autoimmune hepatitis in a patient treated with the tumor necrosis factor inhibitor, etanercept.

K. Nagata, Yoshiko Umekita, A. Okayama, 2011, Internal medicine.

Hepatocyte Growth Factor Accelerates Proliferation of Hepatic Oval Cells in a 2-Acetylaminofluorene/Partial Hepatectomy Model in the Rat

A. Ido, A. Moriuchi, H. Tsubouchi, 2004 .

Loss of Tyrosine Kinase 2 Does Not Affect the Severity of Jak2V617F-induced Murine Myeloproliferative Neoplasm.

K. Nagata, K. Shimoda, T. Miike, 2017, Anticancer research.

Hepatocyte Growth Factor Facilitates the Repair of Large Colonic Ulcers in 2,4,6‐Trinitrobenzene Sulfonic Acid‐Induced Colitis in Rats

K. Nagata, A. Ido, A. Moriuchi, 2005, Inflammatory Bowel Diseases.

Hypermethylation of the wild-type ferrochelatase allele is closely associated with severe liver complication in a family with erythropoietic protoporphyria.

K. Hayashi, K. Nagata, A. Ido, 2004, Biochemical and biophysical research communications.

Etoposide prevents apoptosis in mouse liver with D‐galactosamine/lipopolysaccharide‐induced fulminant hepatic failure resulting in reduction of lethality

S. Hirono, K. Nagata, A. Ido, 2001, Hepatology.

Activation of hepatocyte growth factor in monkey stomach following gastric mucosal injury

K. Miyazawa, S. Nakagawa, K. Hayashi, 2004, Journal of Gastroenterology.

Increased rate of death related to presence of viremia among hepatitis C virus antibody–positive subjects in a community‐based cohort study

K. Hayashi, M. Kohara, K. Nagata, 2009, Hepatology.

Molecular mechanisms of hereditary persistence of alpha-fetoprotein (AFP) in two Japanese families A hepatocyte nuclear factor-1 site mutation leads to induction of the AFP gene expression in adult livers.

K. Hayashi, K. Nagata, A. Ido, 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

Acute Liver Failure Due to Severe Hepatic Metastasis of Small-cell Lung Cancer Producing Adrenocorticotropic Hormone Complicating Ectopic Cushing Syndrome

K. Nagata, K. Shimoda, H. Kataoka, 2019, Internal medicine.

Usefulness of a new immuno‐radiometric assay to detect hepatitis C core antigen in a community‐based population

M. Kohara, A. Ido, H. Tsubouchi, 2005, Journal of viral hepatitis.

Acute hepatic failure due to hepatic involvement by chronic lymphocytic leukemic cells in a patient with chronic hepatitis B

K. Hayashi, A. Ido, H. Tsubouchi, 2003, Journal of gastroenterology.

Development of a rapid semi-quantitative immunochromatographic assay for serum hepatocyte growth factor and its usefulness in acute liver failure.

Katsuhiro Hayashi, K. Hayashi, K. Nagata, 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A*2402, the most common HLA class I allele in East Asia.

H. Tsubouchi, M. Morimoto, K. Sugi, 2001, Journal of hepatology.

TET2 mutation in diffuse large B-cell lymphoma.

K. Nagata, K. Shimoda, T. Miike, 2017, Journal of clinical and experimental hematopathology : JCEH.

TET2 Mutation in Adult T-Cell Leukemia/Lymphoma.

K. Nagata, K. Shimoda, T. Miike, 2015, Journal of clinical and experimental hematopathology : JCEH.

Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms.

K. Nagata, M. Ono, K. Ikeda, 2020, Blood.

Portal vein thrombosis during eltrombopag treatment for immune thrombocytopenic purpura in a patient with liver cirrhosis due to hepatitis C viral infection.

T. Kawaguchi, M. Sata, K. Nagata, 2013, Journal of clinical and experimental hematopathology : JCEH.

Efficacy and safety of sofosbuvir and ledipasvir in Japanese patients aged 75 years or over with hepatitis C genotype 1

S. Hirono, K. Nagata, K. Shimoda, 2017, World journal of hepatology.

Frailty Status Predicts New Long-term Care Insurance Certification in Hepatitis C Patients Receiving Antiviral Therapy

K. Nagata, K. Shimoda, Kenichi Nakamura, 2021, AntiCancer Research.

Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice

K. Nagata, A. Sawaguchi, K. Shimoda, 2020, Leukemia.

Pharmacokinetic study of recombinant human hepatocyte growth factor administered in a bolus intravenously or via portal vein.

A. Ido, A. Moriuchi, H. Tsubouchi, 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system

K. Hayashi, K. Nagata, A. Ido, 2007, Hepatology.

TET 2 mutation in diffuse large B-cell lymphoma

K. Nagata, K. Shimoda, T. Miike, 2017 .

Monocyte-derived fibrocytes elimination had little contribution on liver fibrosis.

K. Nagata, A. Sawaguchi, K. Shimoda, 2019, Hepatobiliary & pancreatic diseases international : HBPD INT.

JSM Gastroenterology and Hepatology

K. Nagata, K. Shimoda, T. Miike, 2014 .

Gastrointestinal Bleeding in Acute Myeloid Leukemia Patients Receiving Intensive Induction Chemotherapy

K. Nagata, K. Shimoda, T. Miike, 2014 .

Association of a genetic polymorphism in ectonucleotide pyrophosphatase/phosphodiesterase 1 with hepatitis C virus infection and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan

K. Hayashi, K. Nagata, A. Ido, 2008, Journal of Gastroenterology.

Transgenic expression of osteoactivin in the liver attenuates hepatic fibrosis in rats.

K. Nagata, A. Ido, A. Moriuchi, 2007, Biochemical and biophysical research communications.

Repeated intravenous injection of recombinant human hepatocyte growth factor ameliorates liver cirrhosis but causes albuminuria in rats.

K. Nagata, A. Ido, A. Moriuchi, 2006, International journal of molecular medicine.

Prediction of Sustained Virological Response to Telaprevir/Simeprevir-Based Triple Therapy in Patients with Genotype 1 Hepatitis C Virus Using Super-Early Viral Response within 2 Weeks

K. Nagata, K. Shimoda, T. Miike, 2017 .

Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation

K. Hayashi, K. Nagata, A. Ido, 2003, Journal of Gastroenterology.

[A case of gastric endocrine cell carcinoma with liver metastasis showing rapid growth during pregnancy and marked reduction by systemic chemotherapy after delivery].

K. Hayashi, K. Nagata, A. Ido, 2006, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

Transforming growth factor-beta-induced stimulation of formation of collagen fiber network and anti-fibrotic effect of taurine in an in vitro model of hepatic fibrosis.

A. Terano, K. Hayashi, A. Ido, 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

A CASE OF VASCULAR ECTASIAS OF THE COLON DETECTED BY ENDOSCOPIC ULTRASONOGRAPHY AND TREATED BY ARGON PLASMA COAGULATION

S. Hirono, K. Hayashi, K. Nagata, 2002 .

Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosis

M. Ikawa, K. Nagata, K. Shimoda, 2019, Blood Cancer Journal.

Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations

K. Nagata, K. Shimoda, T. Miike, 2016, Annals of laboratory medicine.

Effect of hepatocyte growth factor on endogenous hepatocarcinogenesis in rats fed a choline-deficient L-amino acid-defined diet.

K. Nagata, A. Ido, A. Moriuchi, 2006, Oncology reports.

A case of hyperammonemia occurring during treatment of metastatic renal cell carcinoma with axitinib

T. Kamoto, Yuichiro Sato, S. Mukai, 2023, IJU case reports.

A CASE OF IMPACTED DIOSPYROBEZOARS IN GASTRIC ANTRUM TREATED SUCCESSFULLY BY DISSOLUTION THERAPY WITH COLA

K. Nagata, K. Shimoda, T. Miike, 2008 .

Rapidly increasing hepatic hydrothorax induced dyspnea in two cases with liver cirrhosis

K. Hayashi, A. Ido, H. Tsubouchi, 2004 .